121 related articles for article (PubMed ID: 16054689)
1. Variation of LEF-1 mRNA expression in low-grade B-cell non-Hodgkin's lymphoma.
Howe D; Bromidge T
Leuk Res; 2006 Jan; 30(1):29-32. PubMed ID: 16054689
[TBL] [Abstract][Full Text] [Related]
2. Mapping canonical Wnt signaling in the developing and adult retina.
Liu H; Thurig S; Mohamed O; Dufort D; Wallace VA
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5088-97. PubMed ID: 17065530
[TBL] [Abstract][Full Text] [Related]
3. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
[TBL] [Abstract][Full Text] [Related]
4. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of retinal-neurite extension by beta-catenin signaling pathway.
Ouchi Y; Tabata Y; Arai K; Watanabe S
J Cell Sci; 2005 Oct; 118(Pt 19):4473-83. PubMed ID: 16179606
[TBL] [Abstract][Full Text] [Related]
6. Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia.
Khan NI; Bradstock KF; Bendall LJ
Br J Haematol; 2007 Aug; 138(3):338-48. PubMed ID: 17614820
[TBL] [Abstract][Full Text] [Related]
7. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis.
Gutierrez A; Tschumper RC; Wu X; Shanafelt TD; Eckel-Passow J; Huddleston PM; Slager SL; Kay NE; Jelinek DF
Blood; 2010 Oct; 116(16):2975-83. PubMed ID: 20595513
[TBL] [Abstract][Full Text] [Related]
8. Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression.
Yao QM; Li PP; Liang SM; Lu K; Zhu XJ; Liu YX; Zhang F; Yuan T; Wang X
Int J Clin Exp Pathol; 2015; 8(7):7921-8. PubMed ID: 26339357
[TBL] [Abstract][Full Text] [Related]
9. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
Das Gupta A; Shah VI
Hematol Pathol; 1990; 4(1):37-41. PubMed ID: 2187855
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef-dependent transcription.
Torres VA; Tapia JC; Rodriguez DA; Lladser A; Arredondo C; Leyton L; Quest AF
Mol Cell Biol; 2007 Nov; 27(21):7703-17. PubMed ID: 17785436
[TBL] [Abstract][Full Text] [Related]
11. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
[TBL] [Abstract][Full Text] [Related]
12. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
13. Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia.
Finn WG; Singleton TP; Schnitzer B; Ross CW; Stoolman LM
Hum Pathol; 2001 Jan; 32(1):66-73. PubMed ID: 11172297
[TBL] [Abstract][Full Text] [Related]
14. Beta-catenin relieves I-mfa-mediated suppression of LEF-1 in mammalian cells.
Pan W; Jia Y; Huang T; Wang J; Tao D; Gan X; Li L
J Cell Sci; 2006 Dec; 119(Pt 23):4850-6. PubMed ID: 17090604
[TBL] [Abstract][Full Text] [Related]
15. Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.
Lu D; Liu JX; Endo T; Zhou H; Yao S; Willert K; Schmidt-Wolf IG; Kipps TJ; Carson DA
PLoS One; 2009 Dec; 4(12):e8294. PubMed ID: 20011538
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs.
Gebeshuber CA; Sladecek S; Grunert S
Cells Tissues Organs; 2007; 185(1-3):51-60. PubMed ID: 17587808
[TBL] [Abstract][Full Text] [Related]
17. Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis.
Døsen G; Tenstad E; Nygren MK; Stubberud H; Funderud S; Rian E
BMC Immunol; 2006 Jun; 7():13. PubMed ID: 16808837
[TBL] [Abstract][Full Text] [Related]
18. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
19. Quantification of CD20 mRNA and protein levels in chronic lymphocytic leukemia suggests a post-transcriptional defect.
Sarro SM; Unruh TL; Zuccolo J; Sanyal R; Luider JM; Auer-Grzesiak IA; Mansoor A; Deans JP
Leuk Res; 2010 Dec; 34(12):1670-3. PubMed ID: 20674973
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of the Wnt signal by MM-1 through inhibiting expression of the wnt4 gene.
Yoshida T; Kitaura H; Hagio Y; Sato T; Iguchi-Ariga SM; Ariga H
Exp Cell Res; 2008 Apr; 314(6):1217-28. PubMed ID: 18281035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
